Description
GDC-0879 is a potent small-molecule inhibitor of BRAF kinase, including the oncogenic BRAF V600E mutant, a key regulator of the MAPK/ERK signaling pathway. By modulating downstream signaling, GDC-0879 influences cell proliferation and survival, making it a valuable tool for studying pathway dynamics in cancer biology.
GDC-0879 is widely used in cell-based assays to investigate BRAF-driven processes, including tumor growth, pathway activation, and drug resistance mechanisms. Its activity supports both mechanistic studies and the development of targeted therapeutic strategies.
Key Features:
- Potent inhibitor of BRAF kinase, including V600E mutant
- Modulates MAPK/ERK signaling pathway
- High activity in cell-based assays
- Useful for cancer biology and targeted therapy research
Applications:
- MAPK/ERK signaling studies
- Cancer biology and tumor progression research
- Drug resistance and pathway modulation studies
- Target validation and drug discovery
Formulation & Storage:
- Typically supplied as a solid powder
- Soluble in DMSO
- Store at -20°C, desiccated, and protected from light
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Reviews
There are no reviews yet.